Holder | Position | Change | Date | |
---|---|---|---|---|
No active short positions |
Holder | Position | Change (%) | Date | |
---|---|---|---|---|
Millennium International Management LP | 0.74% | 0.11 | 28-Nov-2022 | View History |
Millennium International Management LP | 0.63% | 0.13 | 23-Nov-2022 | View History |
Millennium International Management LP | 0.5% | 18-Nov-2022 | View History | |
Canada Pension Plan Investment Board | 0.45% | 24-Aug-2020 | View History | |
Canada Pension Plan Investment Board | 0.52% | 30-Jul-2020 | View History |
Hutchmed China Limited develops, manufactures, and sells pharmaceutical products. The Company offers drugs for oncology and autoimmune diseases treatment. HUTCHMED (China) is headquartered in Hong Kong and markets its products worldwide.
It was founded in 2000 and listed in London in 2018 under the ticker HCM.